Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2001 Jul;85(1):93–97. doi: 10.1054/bjoc.2001.1846

Vascular endothelial growth factor-C expression and its relationship to pelvic lymph node status in invasive cervical cancer

I Hashimoto 1, J Kodama 1, N Seki 1, A Hongo 1, M Yoshinouchi 1, H Okuda 2, T Kudo 1
PMCID: PMC2363906  PMID: 11437408

Abstract

Vascular endothelial growth factor-C (VEGF-C) has been implicated in lymphangiogenesis, the process of new lymphatics formation. The present study investigated VEGF-C mRNA expression in invasive cervical cancer tissue. Additionally, the association of VEGF-C mRNA with clinicopathological features was examined. VEGF-C mRNA expression was assessed by reverse transcription-polymerase chain reaction using β-action as an internal control. 75 patients presenting with invasive cervical cancer were included in the trial. VEGF-C mRNA expression was markedly higher in tumours in which pelvic lymph node metastasis was diagnosed by magnetic resonance (MR) imaging (P = 0.002). 53 patients displaying stage Ib–IIb cervical cancer underwent radical hysterectomy and pelvic lymphadenectomy. VEGF-C expression was significantly higher in tumours exhibiting deep stromal invasion, pelvic lymph node metastasis and lymph-vascular space involvement (P = 0.016, P = 0.006 and P = 0.036, respectively). Multivariate analysis revealed VEGF-C mRNA expression to be the sole independent factor influencing pelvic lymph node metastasis. Subjects demonstrating VEGF-C mRNA expression displayed significantly poorer prognoses than those lacking VEGF-C mRNA expression (P = 0.049). These findings provide evidence supporting the involvement of VEGF-C expression in the promotion of lymph node metastasis in cervical cancer. Furthermore, examination of VEGF-C expression in biopsy specimens may be beneficial in the prediction of pelvic lymph node metastasis. © 2001 Cancer Research Campaign http://www.bjcancer.com

Keywords: VEGF-C, lymph node metastasis, cervical cancer

Full Text

The Full Text of this article is available as a PDF (84.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akagi K., Ikeda Y., Miyazaki M., Abe T., Kinoshita J., Maehara Y., Sugimachi K. Vascular endothelial growth factor-C (VEGF-C) expression in human colorectal cancer tissues. Br J Cancer. 2000 Oct;83(7):887–891. doi: 10.1054/bjoc.2000.1396. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. André T., Kotelevets L., Vaillant J. C., Coudray A. M., Weber L., Prévot S., Parc R., Gespach C., Chastre E. Vegf, Vegf-B, Vegf-C and their receptors KDR, FLT-1 and FLT-4 during the neoplastic progression of human colonic mucosa. Int J Cancer. 2000 Apr 15;86(2):174–181. doi: 10.1002/(sici)1097-0215(20000415)86:2<174::aid-ijc5>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]
  3. Bunone G., Vigneri P., Mariani L., Butó S., Collini P., Pilotti S., Pierotti M. A., Bongarzone I. Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features. Am J Pathol. 1999 Dec;155(6):1967–1976. doi: 10.1016/S0002-9440(10)65515-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Fujita N., Yaegashi N., Ide Y., Sato S., Nakamura M., Ishiwata I., Yajima A. Expression of CD44 in normal human versus tumor endometrial tissues: possible implication of reduced expression of CD44 in lymph-vascular space involvement of cancer cells. Cancer Res. 1994 Jul 15;54(14):3922–3928. [PubMed] [Google Scholar]
  5. Gunningham S. P., Currie M. J., Han C., Robinson B. A., Scott P. A., Harris A. L., Fox S. B. The short form of the alternatively spliced flt-4 but not its ligand vascular endothelial growth factor C is related to lymph node metastasis in human breast cancers. Clin Cancer Res. 2000 Nov;6(11):4278–4286. [PubMed] [Google Scholar]
  6. Joukov V., Sorsa T., Kumar V., Jeltsch M., Claesson-Welsh L., Cao Y., Saksela O., Kalkkinen N., Alitalo K. Proteolytic processing regulates receptor specificity and activity of VEGF-C. EMBO J. 1997 Jul 1;16(13):3898–3911. doi: 10.1093/emboj/16.13.3898. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Kaipainen A., Korhonen J., Mustonen T., van Hinsbergh V. W., Fang G. H., Dumont D., Breitman M., Alitalo K. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci U S A. 1995 Apr 11;92(8):3566–3570. doi: 10.1073/pnas.92.8.3566. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Kodama J., Seki N., Tokumo K., Hongo A., Miyagi Y., Yoshinouchi M., Okuda H., Kudo T. Vascular endothelial growth factor is implicated in early invasion in cervical cancer. Eur J Cancer. 1999 Mar;35(3):485–489. doi: 10.1016/s0959-8049(98)00410-9. [DOI] [PubMed] [Google Scholar]
  9. Kodama J., Yoshinouchi M., Seki N., Hongo A., Miyagi Y., Kudo T. Angiogenesis and platelet-derived endothelial cell growth factor/thymidine phosphorylase expression in cervical cancer. Int J Oncol. 1999 Jul;15(1):149–154. doi: 10.3892/ijo.15.1.149. [DOI] [PubMed] [Google Scholar]
  10. Kukk E., Lymboussaki A., Taira S., Kaipainen A., Jeltsch M., Joukov V., Alitalo K. VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development. Development. 1996 Dec;122(12):3829–3837. doi: 10.1242/dev.122.12.3829. [DOI] [PubMed] [Google Scholar]
  11. Kurebayashi J., Otsuki T., Kunisue H., Mikami Y., Tanaka K., Yamamoto S., Sonoo H. Expression of vascular endothelial growth factor (VEGF) family members in breast cancer. Jpn J Cancer Res. 1999 Sep;90(9):977–981. doi: 10.1111/j.1349-7006.1999.tb00844.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Maglione D., Guerriero V., Viglietto G., Delli-Bovi P., Persico M. G. Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc Natl Acad Sci U S A. 1991 Oct 15;88(20):9267–9271. doi: 10.1073/pnas.88.20.9267. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Meyer M., Clauss M., Lepple-Wienhues A., Waltenberger J., Augustin H. G., Ziche M., Lanz C., Büttner M., Rziha H. J., Dehio C. A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases. EMBO J. 1999 Jan 15;18(2):363–374. doi: 10.1093/emboj/18.2.363. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Niki T., Iba S., Tokunou M., Yamada T., Matsuno Y., Hirohashi S. Expression of vascular endothelial growth factors A, B, C, and D and their relationships to lymph node status in lung adenocarcinoma. Clin Cancer Res. 2000 Jun;6(6):2431–2439. [PubMed] [Google Scholar]
  15. Ohta Y., Shridhar V., Bright R. K., Kalemkerian G. P., Du W., Carbone M., Watanabe Y., Pass H. I. VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumours. Br J Cancer. 1999 Sep;81(1):54–61. doi: 10.1038/sj.bjc.6690650. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Olofsson B., Pajusola K., Kaipainen A., von Euler G., Joukov V., Saksela O., Orpana A., Pettersson R. F., Alitalo K., Eriksson U. Vascular endothelial growth factor B, a novel growth factor for endothelial cells. Proc Natl Acad Sci U S A. 1996 Mar 19;93(6):2576–2581. doi: 10.1073/pnas.93.6.2576. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Scheidler J., Hricak H., Yu K. K., Subak L., Segal M. R. Radiological evaluation of lymph node metastases in patients with cervical cancer. A meta-analysis. JAMA. 1997 Oct 1;278(13):1096–1101. [PubMed] [Google Scholar]
  18. Seki A., Kodama J., Miyagi Y., Kamimura S., Yoshinouchi M., Kudo T. Amplification of the mdm-2 gene and p53 abnormalities in uterine sarcomas. Int J Cancer. 1997 Sep 26;73(1):33–37. doi: 10.1002/(sici)1097-0215(19970926)73:1<33::aid-ijc6>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
  19. Tsurusaki T., Kanda S., Sakai H., Kanetake H., Saito Y., Alitalo K., Koji T. Vascular endothelial growth factor-C expression in human prostatic carcinoma and its relationship to lymph node metastasis. Br J Cancer. 1999 Apr;80(1-2):309–313. doi: 10.1038/sj.bjc.6690356. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Valtola R., Salven P., Heikkilä P., Taipale J., Joensuu H., Rehn M., Pihlajaniemi T., Weich H., deWaal R., Alitalo K. VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer. Am J Pathol. 1999 May;154(5):1381–1390. doi: 10.1016/S0002-9440(10)65392-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Yamada Y., Nezu J., Shimane M., Hirata Y. Molecular cloning of a novel vascular endothelial growth factor, VEGF-D. Genomics. 1997 Jun 15;42(3):483–488. doi: 10.1006/geno.1997.4774. [DOI] [PubMed] [Google Scholar]
  22. Yonemura Y., Endo Y., Fujita H., Fushida S., Ninomiya I., Bandou E., Taniguchi K., Miwa K., Ohoyama S., Sugiyama K. Role of vascular endothelial growth factor C expression in the development of lymph node metastasis in gastric cancer. Clin Cancer Res. 1999 Jul;5(7):1823–1829. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES